Viewing data from:

ATROPINE SULFATE

ANDA

ATROPINE SULFATE | A212868 | ACCORD HEALTHCARE INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ATROPINE SULFATE(TE code: AP)

API Supply Chain11 active DMFs1 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDATROPINE SULFATE

DMF 289782014

ROLABO OUTSOURCING SLATROPINE SULFATE USP

DMF 293962015

SCL LIFESCIENCES LTDATROPINE SULFATE USP

DMF 296052015

RESONANCE LABORATORIES PVT LTDATROPINE SULFATE

DMF 298032015

MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTDATROPINE SULFATE

DMF 302272016

C-SQUARED PHARMA LTDATROPINE SULFATE USP

DMF 306052016

ALCHEM INTERNATIONAL PRIVATE LTDATROPINE SULFATE USP

DMF 312782016

MATRIX PHARMACORP PRIVATE LTDATROPINE SULFATE USP

DMF 322902017

SS PHARMA LLCATROPINE SULFATE MONOHYDRATE USP

DMF 337812019

HENAN PURUI PHARMACEUTICAL CO LTDATROPINE SULFATE

DMF 364842021

FLOWCHEM PHARMA PVT LTDATROPINE SULFATE USP

DMF 422992025

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveATROPINE SULFATE

DMF 54941984

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 16, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 0.25MG/5ML (0.05MG/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Jul 26, 2021

No patent or exclusivity listings for this strength.

#002 — 0.5MG/5ML (0.1MG/ML)

0 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Jul 26, 2021

#003 — 1MG/10ML (0.1MG/ML)

0 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Jul 26, 2021